Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Explore the groundbreaking immunotherapy trial of MPDL3280A (atezolizumab) in metastatic renal cell carcinoma, its mechanism, results, and impact on cancer treatment.